Predictive Value for Future Arrhythmic Events of Fractal Dimension, a Measure of Time Clustering of Ventricular Premature Complexes, After Myocardial Infarction fn1fn1This study was supported in part by a substudy grant from the Cardiac Arrhythmia Suppression Trial and by contracts from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.  by Anderson, Jeffrey L. et al.
Predictive Value for Future Arrhythmic Events of Fractal Dimension,
a Measure of Time Clustering of Ventricular Premature Complexes,
After Myocardial Infarction
JEFFREY L. ANDERSON, MD, FACC, LABROS A. KARAGOUNIS, MD, FACC,
KENNETH M. STEIN, MD,* FIDELA L. MORENO, MD, ROBERT LEDINGHAM, MS,†
ALFRED HALLSTROM, PHD,† FOR THE CAST INVESTIGATORS§
Salt Lake City, Utah; New York, New York; and Seattle, Washington
Objectives. Our objective was to test fractal dimension (D), a
measure of clustering of ventricular premature complexes (VPCs),
on entry Holter recording as a predictor of future arrhythmic
death and other-cause mortality in postinfarction patients in the
Cardiac Arrhythmic Suppression Trial (CAST).
Background. Nonlinear dynamic methods of signal processing
are being applied in medicine to provide new insights into
apparently “chaotic” biologic events, including cardiac arrhyth-
mias. One such application is the derivation of a fractal D to
describe the clustering of VPCs in time.
Methods. Baseline Holter recordings were analyzed in blinded
manner for 484 patients: 237 died or had a resuscitated cardiac
arrest during follow-up, and 247 matched patients had no events.
Fractal D, measured in four ways, was assessed as a predictor
using Cox regression.
Results. One measure of D (high resolution D) was a significant
univariate (relative hazard ratio 0.79 per SD change, p 5 0.011)
and multivariate (hazard ratio 0.75, p 5 0.046) predictor of
arrhythmic death but not other death (univariate p 5 0.95,
relative hazard 0.95, p 5 0.66). Fractal D was greater (VPCs less
clustered) in those patients free of arrhythmic events. On sub-
group analysis, the predictive value of D resided in the random-
ized patient group (i.e., those who showed VPC suppression
during initial antiarrhythmic drug titration and were randomized
to blinded therapy with active drug or placebo) (multivariate
hazard ratio 0.57, p 5 0.001).
Conclusions. A high resolution fractal D was predictive of
arrhythmic (but not nonarrhythmic) death in a large postinfarc-
tion cohort. Further study of this new signal processing approach
to ambulatory electrocardiographic recording will be of interest.
(J Am Coll Cardiol 1997;30:226–32)
©1997 by the American College of Cardiology
Ambulatory electrocardiographic (ECG) recording (Holter
monitoring) has been extensively used for detection, risk
stratification and therapeutic guidance of ventricular and
supraventricular arrhythmias. Information derived from
Holter monitoring commonly includes the frequency of single
ventricular premature complexes (VPCs), couplets and runs of
ventricular tachycardia. Together with markers of left ventric-
ular dysfunction, the frequency and complexity of ventricular
arrhythmias have been used as prognostic indicators in patients
with structural heart disease, including myocardial infarction
(1–3). However, arrhythmia frequency by itself is an imperfect
marker of risk, and suppression of prognostically important
ventricular arrhythmias does not necessarily predict an im-
proved prognosis (4–6). Hence, other measures of vulnerabil-
ity to life-threatening ventricular arrhythmias are of interest.
Examples of advanced approaches to ECG signal processing
include signal averaging (7,8), heart period variability (9) and
fractal dimension (D) measures of VPC clustering (10).
Deterministic chaos is a term applied to the seemingly
unpredictable behavior that may arise in response to the
internal feedback loops of nonlinear systems. “Chaos theory,”
using the mathematics of nonlinear dynamics, has recently
been applied to assess the complexity of biologic systems,
including the cardiovascular system, enabling measurement of
the output of physiologic systems that generate highly variable
fluctuations resembling “chaos,” in which output is not pro-
portional to input (10–18). The frequency distributions of
heart rate and ventricular arrhythmias over time exemplify two
candidate cardiovascular response systems that may be ana-
lyzed using nonlinear dynamics.
Fractals are a class of geometric patterns that are irregular
but have underlying self-similarity, often on multiple scales,
that classic Euclidean geometry is unable to characterize (11).
The frequency distribution over time of VPCs is a candidate
fractal system. Nonlinear dynamics allow derivation of a fractal
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D to describe systems showing fractal geometry (11), a specific
application of deterministic chaos theory (12,13).
This study tested the predictive values for future cardiovas-
cular events and, in particular, arrhythmic events, of estimates
of fractal D as descriptors of the degree of clustering of VPCs
over time in patients with recent myocardial infarction and
ambient ventricular ectopy who entered and were followed up
in the Cardiac Arrhythmia Suppression Trial (CAST) (4–6,19).
Methods
Study objectives. The main objective of the study was to
determine whether measures of clustering of VPCs in time, as
recorded on a 24-h baseline ambulatory monitor tape and
described by a fractal D (determined by one of several
methods of signal processing), could be used to identify
postinfarction patients at increased risk for sudden death/
cardiac arrest (primary hypothesis) or all-cause death/cardiac
arrest (secondary hypothesis) within the CAST study group.
Patient selection criteria. General entry criteria for CAST
and treatment strategies have been previously reported (4–6).
In brief, patients were required to have had a documented
acute myocardial infarction within 6 to 90 days of study entry,
together with a left ventricular ejection fraction #55%, or
acute myocardial infarction within the window of 90 days to 2
years, coupled with an ejection fraction #40%. In addition,
baseline ventricular ectopy was required (VPC frequency
averaging $6/h on a 24-h ambulatory ECG monitor). Patients
with runs of ventricular tachycardia $15 beats at rate $120
beats/min were excluded.
In addition to receiving standard, physician-directed ther-
apy, patients were randomized to receive encainide, flecainide
or moricizine therapy, and suppressibility of VPCs was tested.
When a drug and dose were found to be effective (achieving
$80% VPC suppression) or partially effective, the patient was
randomized to long-term therapy with active drug or matching
placebo. When none of the tested drugs and doses was effective
or tolerated, the patient was not randomized but was followed
outside of the main CAST study. A total of 3,549 patients were
entered into CAST-I or CAST-II (19). Suppression of arrhyth-
mias was achieved in 2,491 patients and partial suppression in
260 patients, and 635 patients were not randomized to long-
term, blinded use of the study drug because of failure to
achieve even partial suppression or intolerance or because of
miscellaneous reasons. Event rates assessed during long-term
clinical follow-up were those for arrhythmic death plus resus-
citated cardiac arrest and all-cause death plus resuscitated
cardiac arrest.
Selection of patients and control subjects. Patients were
selected for study if they were entered into CAST, had an
analyzable baseline 24-h ambulatory Holter monitor recording
with at least 200 VPCs, were followed long-term and if they
died (of any cause) or had a resuscitated cardiac arrest during
follow-up (n 5 237). An approximately equal number of CAST
patients (n 5 247) who did not have events during follow-up
were selected as control subjects, matched by site and selected
to have approximately similar distributions of important risk
factors as well as treatment assignment (active drug vs. pla-
cebo) and study group status (randomized vs. nonrandomized).
The randomized group (“VPC suppressible”) included 301
patients—145 patients with an event during follow-up and 156
control subjects without an event. The nonrandomized group
included 183 patients—92 patients with an event and 91
control subjects without an event.
Holter tapes from all patients with events and from control
subjects were selected at the central CAST Coordinating
Center (Seattle) and sent to the Fractal Analysis Laboratory
(Salt Lake City) for processing.
Computing fractal D. Fractal D was determined by signal
processing of the baseline 24-h Holter recordings at the core
laboratory in a manner blinded to patient characteristics,
treatment assignment, suppression status and patient outcome.
Computed values for fractal D were then sent back to the
Coordinating Center and incorporated into the CAST data
base.
Holter recordings taken at the individual CAST study sites
were scanned for VPCs at the core laboratory using an
operator-interactive system (Marquette), and the timing of
each VPC from the beginning of the tape was identified to
within 8 ms and entered into an annotated computer file. The
annotated files of the recordings were then used for estimation
of fractal D using the correlation technique of Grassberger and
Procaccia (20), as previously described (21–23). Three esti-
mates for D used a custom-designed program (K.M.S.) to
identify all possible VPC pairs within times of one another
ranging from #1 to #10 min and the time-distance between
them was sorted into 30-s increments (21). (This analysis was
computationally efficient but induced potential lumping and
roundoff error into the estimation of the time interval of VPC
pairing: it looked at intervals between 1 and 10 min but ignored
shorter [,1-min] intervals.)
These three estimates are described:
Initial D. Fractal D was based on the first 200 VPCs only
on the tape. This method has been previously reported (10),
is straightforward, uniformly applicable and least time-
consuming, but D is based on the least information of the
methods.
Minimal D. The minimal D was selected from all Ds
determined on 200 consecutive VPC analyses throughout the
Holter tape. This “worst case” (most clustered) D determina-
tion throughout the 24 h was tested as a possibly better
predictor for events.
Abbreviations and Acronyms
CAST 5 Cardiac Arrhythmia Suppression Trial
D 5 dimension (fractal)
ECG 5 electrocardiogram, electrocardiographic
ln 5 natural logarithm
log 5 logarithm
VPC 5 ventricular premature complex
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Median D. The median D was selected from all Ds deter-
mined by 200 consecutive VPC analyses throughout the Holter
tape. This more representative (median) D was tested to see
whether it would be a still more accurate predictor of arrhyth-
mic risk.
For these measures, the logarithms of VPC pair counts (C)
for each time distance were then correlated with the loga-
rithms of the respective time distance (r) using linear regres-
sion. The slope (D) of the correlation line (log C 5 a 1 D log r)
was taken as the correlation dimension, designated as fractal
D. (If VPCs are distributed uniformly over time, D is greater
[i.e., values are near 1], whereas densely clustered VPCs yield
a smaller D, nearer to 0.)
High resolution D. This fourth (new) estimate differed in
two ways: 1) All VPCs throughout the Holter recording were
used in the analysis; and 2) VPC pairing was sorted to within
a more precise time interval (i.e., to within 1 s) than that
obtained by the other methods (i.e., only to within 1 min).
Specifically, the time interval for analysis of VPC pairings
began with 1 s and was increased by 2-s intervals up to a
maximal interval of 49 s. (These time intervals were chosen
empirically [L.A.K.] because it appeared intuitively more likely
that VPCs paired at short time intervals—that is, in seconds—
would interact to predict arrhythmic risk more than pairings at
long time intervals—minutes to hours. However, the analysis
was much more computer demanding.) Thus, for each “r” time
interval ranging from 1 to 49 s, the number of VPC pairs that
occurred throughout the tape was counted (“total count”). The
relative pair count (C[r]) associated with each “r” interval was
then computed as the total count for that “r” divided by the
square of the number of VPCs in the entire tape. Then, high
resolution D is the slope of the line relating log (relative
counts) to log (interval lengths)—that is, log C(r) 5 a 1 b log
(r), determined by linear regression using the method of least
squares (24,25). A graphic example is given in Figure 1. Linear
regression yielded excellent correlation coefficients (average
[6SD] r 5 0.97 6 0.03, sample n 5 57).
In a computer-based feasibility and comparability study,
high resolution D and median D were assessed by one of us
(K.M.S.) for their ability to estimate true D by using a series of
computer-simulated VPC sets. The high resolution D algo-
rithm gave excellent approximations of theoretic (computer-
generated) fractal Ds, with a correlation coefficient between
theoretic and calculated values of 0.97 for VPC sets .200 (as
in our study), although it tended to slightly but systematically
overestimate D (i.e., by giving values of D slightly over 1). In
contrast, the median D algorithm yielded estimates that
showed a poorer correlation with theoretic D (correlation
coefficient 0.85) and systematically underestimated true D.
Statistical approach to risk analysis. Univariate and mul-
tivariate Cox regressions (26) were performed for each esti-
mate of D, with D entered as a continuous variable, for
predicting survival to 1) arrhythmic death or resuscitated
cardiac arrest; 2) nonarrhythmic death; and 3) total (all-cause)
death or resuscitated cardiac arrest. Statistical (p) value limits
for removing and entering variables from the stepwise model
were 0.15 and 0.10, respectively. Six covariates were prospec-
tively selected as candidate predictors and were entered along
with fractal D in the stepwise multivariate analyses: age,
gender, natural logarithmic (ln) VPC/h, ejection fraction,
history of congestive heart failure and randomization status
(VPCs “suppressible,” patient randomized to blinded antiar-
rhythmic drug or placebo: yes/no), and, in randomized pa-
tients, drug treatment status (active or placebo). No correction
in p values for the multiplicity of fractal D analyses, thought to
be correlated estimates of the same underlying measure, were
made.
The first analysis assessed fractal D as a predictor in all
Holter-evaluable patients with events compared with their
respective control subjects. The secondary analyses evaluated
the predictive value of D and other baseline factors in the two
distinct subgroups: 1) the “randomized” group: patients were
randomized to “effective” (or partially effective), blinded ther-
apy or to placebo. These patients were followed in the main
CAST studies; 2) the “nonrandomized” group: antiarrhythmic
drug testing was ineffective or not tolerated. Patients were not
randomized to therapy and were followed outside of the main
CAST studies.
Results
Baseline characteristics. Selected baseline characteristics
of the overall study group and subgroups are presented in
Table 1. Patients (with death or resuscitated cardiac arrest)
and control subjects (without events) were well matched,
except that patients had a shorter duration of follow-up (as
expected) and somewhat more commonly had a history of
heart failure (p 5 0.02). Patients in the nonrandomized group
were slightly older (p 5 0.081), had a higher incidence of heart
failure (p 5 0.037), a higher rest heart rate (p 5 0.0056) and
tended to have a lower ejection fraction (p 5 0.058), but had
fewer VPCs/h (p 5 0.047) and a shorter average follow-up
(exposure) time.
Figure 1. Graphic example of fractal D (high resolution D) deter-
mined as the slope of the plot of ln (relative VPC pair count) versus ln
(VPC pair interval) (in seconds) (see Methods for details). Note strong
terminal linearity of plot. For this patient, D 5 0.949 and r 5 0.998.
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Four estimates of fractal D. Average estimates of D, using
each of the four methods, are presented in Table 1 for all
patients and for the randomization subgroups. As expected,
average minimal D was lower than initial D or median D.
Average high resolution D values were found to be higher than
values determined by the other methods. Values for minimal D
(p 5 0.018) and high resolution D (p 5 0.066) also differed by
randomization status.
The first three estimates of D were significantly correlated
(r 5 0.56 to 0.75) and had relatively large coefficients of
variation (SD/mean): 4.3, 6.3 and 9.1 for minimal, initial and
median D, respectively. Moreover, none predicted risk univa-
riately or multivariately. High resolution D was not correlated
with any of these first three estimates and had a smaller
coefficient of variation—3.8. The subsequent discussion fo-
cuses on high resolution D.
High resolution D as a univariate predictor in the overall
group. High resolution D was a significant univariate predic-
tor of events in the overall group in the Cox regression analysis.
For arrhythmic death/cardiac arrest, the primary outcome of
interest, D yielded a global chi-square of 6.51 (p 5 0.01) (Table
2). The relative hazard ratio for high resolution D was 0.79 per
SD separation in high resolution D. Fractal D was greater
(VPCs less clustered) in event-free patients (1.102 6 0.02
[SEM]) than in those with arrhythmic events (1.033 6 0.02).
However, D did not discriminate nonarrhythmic death, aver-
aging 1.102 6 0.02 in event-free patients and, similarly, 1.102 6
0.03 in those with events.
Multivariate predictors in the overall group. Four vari-
ables, including total D, were entered into the Cox multivariate
predictive model of arrhythmic death/cardiac arrest (Table 3):
randomization status (i.e., VPCs “suppressible,” patient ran-
domized to drug or placebo: yes/no) (p , 0.001), ejection
fraction (p 5 0.010), high resolution D (p 5 0.046) and
ln VPC/h (p 5 0.016). The multivariate relative hazard ratio
for high resolution D was 0.79 per SD. (History of heart failure
did not achieve significance as a univariate predictor of ar-
rhythmic death/cardiac arrest [p 5 0.08], and its predictive
power was further reduced by the entry of ejection fraction
into the multivariate model.)
Two variables, not including high resolution D, were en-
tered into the Cox multivariate predictive model of nonar-
rhythmic death (Table 4): randomization status (p , 0.002)
and age (p , 0.001). The hazard ratio for high resolution D
was 0.95 (p 5 0.66).
For combined events (total death), randomization status
(p , 0.001), ejection fraction (p 5 0.003), ln VPC/h (p 5
0.039) and high resolution D (p 5 0.018) were entered.
Univariate prediction in randomized patients. Given the
importance of randomization status as a predictor of events,
we next evaluated whether high resolution D was specifically of
predictive value in randomized (“suppressible”) patients. (In-
deed, a significant [p 5 0.01] interaction between randomiza-
Table 1. Baseline Characteristics by Randomization and Therapy Group Status
Characteristic
Total
(n 5 484)
Case
(n 5 237)
Control
(n 5 247)
Nonrandomized
(n 5 183)
Active
(n 5 157)
Placebo
(n 5 144)
Death/CA status
Event 237 237 0 92 72 73
Censored 247 0 247 91 85 71
Arrhythmic death/CA
Event 130 130 0 55 40 35
Censored 354 107 247 128 117 109
Male (%) 81 78 83 81 78 83
Age (yr) 64.1 64.4 63.8 65 63.7 63.5
Exposure (mo) 21.8 13.8 29.5 12.3 27.3 28
ln VPCs/h (base) 4.18 4.26 4.1 4.04 4.35 4.17
Ejection fraction (%) 28.3 27.5 29.1 27.2 27.8 30.4
Heart rate (beats/min) 77.8 78.7 76.9 79.7 76.1 77
Previous CHF (%) 31.0 35.9 26.3 36.6 30.6 24.3
Initial fractal D 0.863 6 0.15 0.87 0.855 0.874 0.851 0.86
Minimal fractal D 0.758 6 0.19 0.769 0.747 0.783 0.736 0.749
Median fractal D 0.898 6 0.10 0.904 0.892 0.907 0.888 0.897
High resolution fractal D 1.083 6 0.29 1.064 1.102 1.052 1.106 1.098
CA 5 cardiac arrest; CHF 5 congestive heart failure; D 5 dimension; ln 5 natural logarithm; VPCs 5 ventricular premature complexes.
Table 2. Univariate Predictive Value of High Resolution Dimension
in Cox Regression Model By Therapy Group Status
Outcome Measure
Overall
Group
Randomized
Patients
Nonrandomized
Patients
Arrhythmic death/CA
Coefficient 20.8008 21.4278 —
Chi-square 6.51 11.14 0.23
p value 0.011 0.001 0.63
Nonarrhythmic death
Chi-square 0.00 0.10 0.02
p value 0.95 0.76 0.88
Values represent global chi-square and p values for overall group and
randomized patients and entry chi-square and p values for nonrandomized
patients.
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tion status and predictive value of high resolution D for
arrhythmic death/cardiac arrest was found on analysis of
variance for the total patient group.)
High resolution D was a highly significant univariate pre-
dictor in the randomized patient group in the Cox regression
analysis (Table 2). For arrhythmic death/cardiac arrest, the
relative hazard ratio was 0.66 and global chi-square 11.14 (p 5
0.001). Fractal D was greater (VPCs less clustered) in event-
free patients (1.134 6 0.02 [SEM]) than in those with events
(1.006 6 0.03). Two-thirds of patients with arrhythmic events
had “low” (less than median) total D (p , 0.001) compared
with less than one-half of patients without events (Fig. 2).
In contrast, D did not predict nonarrhythmic death: global
chi-square 0.10 (p 5 0.756). Fractal D averaged 1.134 6 0.04 in
those with nonarrhythmic events, and, similarly, 1.134 6 0.02
in event-free patients.
Predictive value of high versus low fractal D. Sensitivity of
“low” versus “high” high resolution D (Fig. 2) for an arrhyth-
mic event or death was 64%, specificity 53%, positive predic-
tive value 31%, negative predictive value 82% and overall
predictive accuracy 56%.
Multivariate predictors in randomized patients. Three
variables were entered into the Cox multivariate model as
predictors of risk of arrhythmic death/cardiac arrest: high
resolution D (p 5 0.001), relative hazard ratio 0.57, ln VPC/h
(p 5 0.010) and age (p 5 0.072).
One variable, age (p 5 0.027), was entered into the
multivariate model as a predictor of risk of nonarrhythmic
death.
Predictors in nonrandomized patients. High resolution D
was neither a univariate (Table 2) nor multivariate predictor in
the nonrandomized patient group. For this group, the multi-
variate model selected only a history of congestive heart failure
(p 5 0.045) as a predictor of arrhythmic death/cardiac arrest
and age (p 5 0.008) as a predictor of nonarrhythmic death.
Discussion
Synthesis of overall findings. Among postinfarction pa-
tients with ventricular ectopy and left ventricular dysfunction
who qualified for the CAST study and were followed for up to
3 years, high resolution D was found to be a significant
univariate and multivariate predictor of arrhythmic death or
cardiac arrest, adding to the predictive value of VPC frequency
alone, with D being smaller (VPCs more clustered) in patients
with arrhythmic events than in those with no events or
nonarrhythmic events.
An additional finding was the interaction between random-
ization status and high resolution D for arrhythmic events: D
was predictive in randomized (VPC suppressible) but not in
nonrandomized (nonsuppressible) patients. (In contrast, al-
though the adverse mortality effects of active drug therapy with
encainide, flecainide and moricizine after an infarction were
well demonstrated by CAST [4–6], assignment to active drug
versus placebo therapy did not interact with the predictive
value of fractal D.) Nonrandomized patients differed from
randomized patients at baseline in several important respects:
they were older, had a higher incidence of heart failure, had
lower ejection fractions and had higher rest heart rates, but
fewer VPCs. Nonrandomized patients thus were sicker, with
poorer ventricular function, arrhythmias unresponsive to ther-
apy and mortality risk perhaps almost exclusively determined
by ventricular dysfunction. In any event, fractal D was not a
useful predictor in patients selected by their unresponsiveness
to antiarrhythmic therapy. Suppressibility as a marker of good
prognosis (and nonsuppressibility of poor prognosis) has been
Table 3. Multivariate Cox Regression Model of Arrhythmic Death/Cardiac Arrest
Step
No.
Variable
Entered DF
Log
Likelihood
Improvement
Chi-Square p Value
Global
Chi-Square p Value Coefficient
0 2746.5
1 Randomization status 1 2737.3 18.45 ,0.001 20.38 ,0.001 20.8237
2 EF 2 2734 6.72 0.01 26.6 ,0.001 20.0182
3 High resolution D 3 2732 3.99 0.046 30.46 ,0.001 20.9786
4 ln VPCs/h 4 2729.1 5.79 0.016 36.34 ,0.001 0.1977
Seven variables were considered in the stepwise model: high resolution dimension, age, gender, natural logarithmic ventricular premature complexes, ejection
fraction, history of heart failure and randomization status (qualified, received blinded therapy: yes/no). Statistical (p) values for removal and entry were 0.15 and 0.10,
respectively. DF 5 degrees of freedom; EF 5 ejection fraction; other abbreviations as in Table 1.
Table 4. Multivariate Cox Regression Model of Nonarrhythmic Death
Step
No. Variable Entered DF
Log
Likelihood
Improvement
Chi-Square p Value
Global
Chi-Square p Value Coefficient
0 2591.344
1 Age 1 2585.035 12.60 ,0.001 11.617 0.001 0.0422
2 Randomization status 2 2580.091 9.89 0.002 22.496 0.000 20.6940
Seven variables were considered in the stepwise model: high resolution dimension, age, gender, natural logarithmic ventricular premature complexes, ejection
fraction, history of heart failure and randomization status (qualified, received blinded therapy: yes/no). Statistical (p) values for removal and entry were 0.15 and 0.10,
respectively. DF 5 degrees of freedom.
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previously noted in the CAST (and other) postinfarction
cohorts (4–6,27–30).
Variability in predictive value of fractal D measures. Only
one of the two essentially different approaches to estimating
fractal D (i.e., high resolution D) was predictive in the CAST
group. The first three estimators were highly correlated with
each other but showed high noise/signal ratios (large vari-
ances) and were unpredictive of events.
Uniquely, high resolution D takes into account all VPCs
throughout the 24 h of recording and analyzes all possible
pairings at short to intermediate times (,1 to 50 s). The results
showed that this estimate of D added independently to the
predictive value of ln VPC frequency in multivariate modeling,
especially for fatal arrhythmic events. (The association of D
and ln VPCs was weak [r 5 0.41, data not shown].) This result
suggests that the pattern of VPC pairings at short time
intervals—seconds—predicts risk of arrhythmic events better
than at long time intervals—minutes to hours—and may be
important to the predictive accuracy of fractal D determina-
tion.
Comparisons with other studies. The application of non-
linear dynamic methods such as fractals to cardiac rhythm
disorders is still in its infancy. Stein and Kligfield (10) retro-
spectively examined ambulatory ECG data in 18 patients with
severe ischemic or nonischemic dilated cardiomyopathy who
had been followed from the time of monitoring for as long as
4 years. A difference in survival (p , 0.002) was observed when
fractal D (determined on the initial 200 VPCs, comparable to
“initial D”) was separated at the median value. Patients with a
higher D (less clustered) showed better survival at 6 months,
with differences closing by 24 months.
This measure of fractal D also was evaluated as a prognostic
marker in 39 patients with advanced valvular heart disease
(severe mitral insufficiency) and .200 VPCs/day (22). Patients
were classified according to ventricular performance (left and
right ventricular ejection fractions #45% or .45% and #30%
or .30%, respectively) and fractal D (divided at the median
value). An excess of sudden deaths was observed in those with
poor performance and clustered VPCs compared with poor
performance and uniform VPCs (four of seven vs. one of five,
p 5 0.02). No deaths occurred in those with good ventricular
performance.
Preliminary findings on the predictive value of fractal D in
patients being treated for life-threatening ventricular arrhyth-
mias also has been recently reported in 105 patients (31). Only
fractal D and sotalol therapy (vs. class I drugs) were found to
be independent predictors for arrhythmia recurrence among
10 baseline and treatment variables.
In contrast to these positive results, a preliminary study in
postinfarction patients with ventricular ectopy enrolled in the
Cardiac Arrhythmia Pilot Study (CAPS) failed to find “initial”
fractal D (determined on the first 200 VPCs) to be predictive
of outcome (32). The present, expanded study from CAST
confirms this negative result for “initial D” in the postinfarc-
tion cohort but indicates that another estimate, high resolution
D, may be predictive.
Study strengths and limitations. This analysis used a large
data base (484 events among 3,549 patients) in a carefully and
prospectively studied population (CAST). The substudy hy-
pothesis and plan were defined prospectively, before analysis
was undertaken, and fractal Ds were estimated at a core
laboratory in a manner blinded to patient characteristics and
outcomes. The result was positive: high resolution D was found
to be a moderately robust predictor of arrhythmic death, with
a relative hazard ratio of 0.79 for patients 1 SD apart in high
resolution D. Importantly, high resolution D was specific for
arrhythmic death but did not predict nonarrhythmic death. As
with other data base–derived studies, the strength of conclu-
sions is less than that inferrable from an entirely prospective
study, and results should be regarded as preliminary and
replicated in future studies.
Patients with and without events showed overlapping values
for fractal D, suggesting that it may be useful primarily as a
research tool or in conjunction with other factors as a clinical
predictor. Also, D may be predictive only in a portion of the
spectrum of postinfarction patients (i.e., in patients whose
VPCs are “suppressible” [our randomized patient group] and
not in those with greater cardiac dysfunction and nonsuppress-
ible VPCs [our nonrandomized group]).
The ideal method of estimating fractal D is unknown.
Although our high resolution algorithm for estimation of D
appears to be an improvement over previous measures, it still
has limitations, including a systematic overestimation of theo-
retic values. Additional refinements should be sought.
Whether and to what extent fractal D is a true measure of
“deterministic chaos” is not addressed in our report and is
controversial (33). Currently, we view fractal D analysis as an
innovative approach to signal processing of the ECG whose
research value, clinical utility and mechanistic meaning remain
to be fully determined. It should be recognized that the
mechanisms influencing the distribution of VPCs in time and
causing VPC clustering are unknown. The role of VPC clus-
tering in triggering arrhythmic events, if any, is likewise unclear
and will require further study. Nonetheless, fractal analysis, a
Figure 2. Distribution of high resolution D values above and below the
median (1.102) in patients (Pts) with and without subsequent arrhyth-
mic death or resuscitated cardiac arrest during follow-up. The differ-
ence in D values between the groups was significant by both analysis of
variance (p 5 0.0009) and simple chi-square analysis (p 5 0.01) of
values dichotomized at the median.
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new approach to signal processing of the ambulatory ECG
recording, appears to be promising, and further refinement
and testing are indicated.
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